BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioNJ - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioNJ
X-ORIGINAL-URL:https://bionj.org
X-WR-CALDESC:Events for BioNJ
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261029T110000
DTEND;TZID=America/New_York:20261029T120000
DTSTAMP:20261018T230659Z
CREATED:20261002T154510Z
LAST-MODIFIED:20261018T230659Z
UID:18858-1793271600-1793275200@bionj.org
SUMMARY:2026 BioNJ Legal Compliance & Regulatory Forum Webinar
DESCRIPTION:Side Effects May Include Longer Commercials: The Coming Fight Over DTC Advertising \n\n\n\nThursday\, October 29 | 11:00 a.m.-12:00 p.m. | Webinar \n\n\n\n\nRegister Today for Free!\n\n\n\n\nFDA is considering rulemaking that could fundamentally reshape DTC advertising by eliminating the “major statement” and “adequate provision” paradigm for broadcast advertising of prescription drugs. Practically\, this would require substantially more disclosure of risk information to appear in broadcast ads for prescription drugs\, potentially making them infeasible. Such a change could have significant legal\, practical and economic implications for biopharmaceutical companies\, broadcasters and others involved in DTC advertising. \n\n\n\nJoin us on October 29 for “Side Effects May Include Longer Commercials: The Coming Fight Over DTC Advertising\,” where our experts will explore what the potential rule could entail\, the political and procedural dynamics that may shape an accelerated rulemaking process\, and the First Amendment\, statutory and administrative-law issues likely to arise in any legal challenge. \n\n\n\nAdditionally\, we’ll discuss industry reactions and explore the practical question at the center of the debate: If the rule is finalized\, can DTC television advertising adapt — or would companies need to rethink the medium altogether? \n\n\n\nOur Panel of Experts Include: \n\n\n\n\n\n\n\n\n\nTorrey CopePartnerSidley Austin LLP \n\n\n\n\n\n\n\n\n\nNikki UlrichChief Legal OfficerPatientPoint \n\n\n\n\n\n\n\n\n\nDiscussion LeadSheetal PatelChief Compliance OfficerJohnson & Johnson Innovative Medicine \n\n\n\n\n\n\n\n\n\nDiscussion LeadMark GaydosHead\, Labeling\, Advertising & PromotionGlobal Regulatory ScienceModerna
URL:https://bionj.org/event/2026-bionj-legal-compliance-regulatory-forum-webinar/
END:VEVENT
END:VCALENDAR